Whole Plant Foods Target All 10 Cancer Hallmarks Better Than Single Drugs
Plant compounds naturally target multiple cancer pathways simultaneously, offering advantages over pharmaceutical approaches.
20 articles
Plant compounds naturally target multiple cancer pathways simultaneously, offering advantages over pharmaceutical approaches.
Glycidol, a toxic compound formed during oil refining, damages DNA and may explain higher cancer rates in fried food consumers.
Scientists found drugs that kill senescent 'zombie cells' by blocking their key survival protein, shrinking tumors in mice.
Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.
New research suggests people eating organic foods most frequently have significantly lower cancer rates than conventional food consumers.
A small molecule called UNI418 shuts down cancer cells' DNA repair machinery, making drug-resistant tumors vulnerable to treatment again.
New poll reveals major knowledge gap about processed meat and colorectal cancer, but plant-based diets can cut risk by 22%.
A protein called HOXD13 drives skin cancer growth and shields tumors from immune cells β disabling it could unlock powerful new treatments.
Northwestern researchers dramatically boosted cancer vaccine effectiveness by simply repositioning one protein fragment on their nanovaccine.
New research reveals colorectal cancer has distinct microbial communities that could improve diagnosis and personalized treatment approaches.
A once-undruggable cancer driver has finally been targeted, cutting death risk by 60% in a landmark 500-patient trial.
When tumors hide from killer T cells, they accidentally expose themselves to helper T cells that trigger a lethal iron-driven cell death process.
Breakthrough non-invasive device offers new hope for pancreatic cancer patients with at-home treatment option.
Scientists discover nerve fibers create a self-sustaining loop that accelerates pancreatic cancer development before tumors even form.
A newly identified molecule called SLAMF6 exhausts cancer-fighting T cells from within β and blocking it may revive failed immunotherapies.
Researchers identify N4BP2, the enzyme behind chromothripsis - a genetic catastrophe that helps one in four cancers rapidly evolve and resist treatment.
New research reveals how tumors reprogram neutrophils to produce CCL3, turning immune defenders into cancer allies.
McGill scientists boosted NK cell cancer-killing power using reversible drug treatment, targeting leukemia, glioblastoma, and triple-negative breast cancer.
When the DNA-repair gene EXO1 is overproduced, it damages DNA instead of fixing itβexposing a hidden vulnerability in multiple cancers.
Redesigned immunotherapy injected into one tumor triggered complete cancer remission in 2 of 12 patients, with untreated tumors also disappearing.